ZOSANO PHARMA Forum: Community User: Lisa

🤣🦾

Nun ist 1,45😉

Bei ca. 1.44 diese Woche bis anhin meist Schluss

Nennt man auch Diskussion, muss man sich nicht beteiligen oder kommentieren wenn man nicht will , danke für deinen Input 👌

Gut das heute überhaupt nicht interessant ist,was bringen euch solche sinnlosen Kommentare? 🤦‍♂️

Kommt heut evtl auch wieder unter die Räder 😎

Zosano Pharma Announces Agreement to Collaborate with Mitsubishi Tanabe Pharma Corporation FREMONT, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a feasibility study agreement with Mitsubishi Tanabe Pharma Corporation, a global pharmaceutical company that develops and commercializes innovative therapies for patients addressing unmet medical needs, centered on its priority disease areas — autoimmune diseases, diabetes and kidney diseases, central nervous system diseases, and vaccines. “Our agreement with Mitsubishi Tanabe Pharma Corporation allows us to combine our proprietary transdermal microneedle drug delivery platform with Mitsubishi Tanabe Pharma Corporation’s drug development candidate,” said Steven Lo, President and CEO of Zosano. “We expect through this partnership, to demonstrate the broad applicability of our platform for making a difference in the lives of patients when combined with pharmaceutical products that address significant unmet medical needs.” Under the agreement, Zosano will evaluate the feasibility of formulating a pharmaceutical agent being developed by Mitsubishi Tanabe Pharma Corporation for administration in humans, with its proprietary microneedle patch system. Defined research and development activities will include both in vitro and in vivo phases. Mitsubishi Tanabe Pharma Corporation receives the right to exercise an option to negotiate an exclusive license to the relevant Zosano technologies in the defined field, which exercise will be dependent on the outcome of the studies. Financial terms and the identity of the Mitsubishi Tanabe Pharma Corporation molecule and development program are not disclosed.

Des ist gut 👍

Item 8.01 Other Events. As previously reported, on March 26, 2020, Zosano Pharma Corporation (the “Company”) received a notice from The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that the Company was not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. On August 14, 2020, the Company received a notice from Nasdaq notifying the Company that it has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Listing Rule 5550(a)(2). The letter noted that for ten consecutive business days, from July 31, 2020 to August 13, 2020, the Company evidenced a closing bid price of its common stock that was greater than or equal to the $1.00 minimum requirement. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the matter closed.

Da scheint jemand die Bremse gezogen zu haben

💪🏻

Vorbörslicher Handel 1,790 +0,150 +9,146%

Hoffe aber auch auf 4$

Vor dem 20. Oktober könnte aber schon was gehen

Wird sich wohl bis Mitte/ Ende September eher seitwärts bewegen - aber auch das nur aus Bauch befürchtet

Reines Bauchgefühl durch querlesen in diversen Foren